Cold medicine

Teen Misuse of OTC Cough Medicine Remains at Historic Lows

Retrieved on: 
Wednesday, December 18, 2019
Mental health, Teens, Parenting, Public policy, Government, General Health, Pharmaceutical, Consumer, Health, Public policy, Other Policy Issues, Psychoactive drugs, Drugs, Neurochemistry, Dissociative drugs, NMDA receptor antagonists, Nicotinic antagonists, Antitussives, Morphinans, Dextromethorphan, Cold medicine, Abuse, CHPA

When first reported in 2006, the number of teens abusing OTC cough medicines was nearly twice that amount but has declined significantly since then.

Key Points: 
  • When first reported in 2006, the number of teens abusing OTC cough medicines was nearly twice that amount but has declined significantly since then.
  • CHPA is encouraged to see that teen DXM abuse rates remain low, said CHPA President and CEO Scott Melville.
  • For more than a decade, CHPA has pushed forward in an aggressive effort aimed at decreasing teen DXM abuse rates.
  • Weve also worked with state lawmakers across the country to address the issue of teen DXM abuse with age-restriction laws.

With Sick Season Approaching, Theraflu® Expands #1 Hot Liquid Cold and Flu Treatment Portfolio* With Targeted Cough Relief Treatment

Retrieved on: 
Tuesday, October 15, 2019
Songs, Cold medicine, Common cold, Influenza treatment, Cold, Cough

New Theraflu Cough Relief contains a 2-in-1 formulation for effective relief of dry and wet cough in a warm soothing liquid.

Key Points: 
  • New Theraflu Cough Relief contains a 2-in-1 formulation for effective relief of dry and wet cough in a warm soothing liquid.
  • Theraflu Cough Relief is the newest addition to the hot liquid cold and flu treatment product line.
  • With consumers increasingly integrating sensorial experiences into their wellness routine, Theraflu offers a variety of hot liquid powder products as a way for cold and flu sufferers to treat their symptoms.
  • "We want to make it easier for consumers this cold and flu season by delivering relief when they need it most.

Global Chronic Refractory Cough Pipeline Insight Report 2019 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 17, 2019
Health, Pharmaceutical, Cough, Cold medicine, Drug pipeline

The "Chronic Refractory Cough Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Chronic Refractory Cough Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • Chronic Refractory Cough (CRC)-Pipeline Insight, 2019 report outlays comprehensive insights of present scenario and growth prospects across the indication.
  • A detailed picture of the Chronic Refractory Cough pipeline landscape is provided which includes the disease overview and Chronic Refractory Cough treatment guidelines.
  • The assessment part of the report embraces, in depth Chronic Refractory Cough commercial assessment and clinical assessment of the pipeline products under development.

Texas Signs Age-Restriction Law to Curb Teen Cough Medicine Abuse

Retrieved on: 
Monday, May 20, 2019
Women, Health, Public policy, Government, Healthcare reform, Pharmaceutical, Public policy, State, Local, Parenting, Teens, Retail, Other Retail, Consumer, Family, MEN, Psychoactive drugs, Drugs, Neurochemistry, Substance abuse, Antitussives, Dextromethorphan, Morphinans, Cold medicine, Abuse

Texas is the 19th state to prohibit the sale of OTC cough medicine to minors, joining other large states, including California, New York, and Florida.

Key Points: 
  • Texas is the 19th state to prohibit the sale of OTC cough medicine to minors, joining other large states, including California, New York, and Florida.
  • For over a decade, OTC manufacturers have worked alongside anti-substance abuse advocates and lawmakers to curb teen cough medicine abuse, said CHPA President and CEO Scott Melville.
  • These types of efforts are critical while the nation addresses substance abuse as a major public health issue.
  • In addition to supporting age-restriction legislation, CHPA works to reduce teen DXM abuse by increasing parental and community awareness through its Stop Medicine Abuse campaign, working closely with organizations such as the Community Anti-Drug Coalitions of America (CADCA).

Peroxfarma to Bring 100 Percent Natural Epaplus Immuncare Cough Supplement to America

Retrieved on: 
Friday, March 29, 2019
Articles, Health, Academic disciplines, Pharmacokinetics, Dietary supplement, Dose, Honey, Cold medicine, Nutrition

Epaplus Immuncare is a 100 percent natural cough syrup that soothes the throat and strengthens the immune system.

Key Points: 
  • Epaplus Immuncare is a 100 percent natural cough syrup that soothes the throat and strengthens the immune system.
  • Its ingredients include vitamins C, B2, B3, honey, and plant extracts that have been used to strengthen the immune system.
  • In addition to Immuncare, Peroxfarma's nutritional supplements include Epaplus Arthicare, Epaplus Sleepcare, Epaplus Skincare, Epaplus Vigorcare, Epaplus Digestcare, and Epaplus Vitalcare.
  • As we like to say at Peroxfarma, our mission is to bring 'an extra dose of health to people'."

West Virginia Becomes 18th State to Adopt Age-18 Sales Law on Cough Medicine

Retrieved on: 
Tuesday, March 26, 2019
Convenience store, Women, Health, Public policy, Government, Healthcare reform, Law enforcement, Emergency services, Pharmaceutical, Other Health, Other Policy Issues, Public policy, State, Local, Children, Teens, Retail, Supermarket, Other Retail, Consumer, Family, MEN, Psychoactive drugs, Drugs, Neurochemistry, Antitussives, Morphinans, Dextromethorphan, Over-the-counter drug, Cold medicine, Cough, CHPA, Recreational use of dextromethorphan

To combat teen abuse of over-the-counter (OTC) medicines containing the cough suppressant dextromethorphan (DXM), West Virginia Governor Jim Justice signed into law S.B.

Key Points: 
  • To combat teen abuse of over-the-counter (OTC) medicines containing the cough suppressant dextromethorphan (DXM), West Virginia Governor Jim Justice signed into law S.B.
  • West Virginia is now the 18th state to pass an age-18 sales law, joining states across the country in recognizing that limiting teen access to DXM is a proven way to prevent abuse, said Consumer Healthcare Products Association (CHPA) President and CEO Scott Melville.
  • Smart public policy and education are both vitally important to combating teen OTC cough medicine abuse, continued Melville.
  • In 2012, California became the first state to prohibit sales of DXM-containing products to minors.